02/11/2026
GLP-1 medications are being prescribed in healthcare systems that rarely screen for eating disorders, even though more than 90% of people with EDs are not underweight.
👉🏼That means many people struggling with restriction, binge-restrict cycles, food preoccupation, or body image distress may be labeled “good candidates” without a full picture of risk.
The eating disorder community cannot be an afterthought in the GLP-1 conversation.
We need:
• routine ED screening before prescribing
•how food noise language can mask disordered eating symptoms
• recognition that EDs happen in bodies of all sizes
• real informed consent — not just marketing language
🗣️ This isn’t about whether these medications should exist.
It’s about whether people are being properly assessed and protected. 🫶🏻
🎙️ We break this down in this week’s episode of Stop, Collaborate, and Listen.
Comment “episode” and we’ll send you the link!